Wealthspire Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Wealthspire Advisors, LLC

$9.71 Billion
Q3 2024

A detailed history of Wealthspire Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Wealthspire Advisors, LLC holds 792 shares of VRTX stock, worth $323,278. This represents 0.0% of its overall portfolio holdings.

Number of Shares

792

Previous 633 25.12%

Holding current value

$323,278

Previous $296,000 24.32%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$460.0 - $505.78 $73,140 - $80,419	159 Added 25.12%	792 $368,000
Q2 2024 Aug 08, 2024	SELL	$392.81 - $485.53 $42,423 - $52,437	-108 Reduced 14.57%	633 $296,000
Q1 2024 May 06, 2024	SELL	$407.69 - $446.08 $92,953 - $101,706	-228 Reduced 23.53%	741 $309,000
Q4 2023 Feb 06, 2024	BUY	$343.0 - $410.68 $106,330 - $127,310	310 Added 47.04%	969 $394,000
Q3 2023 Nov 06, 2023	SELL	$338.18 - $362.46 $338 - $362	-1 Reduced 0.15%	659 $229,000
Q2 2023 Jul 31, 2023	BUY	$314.42 - $351.91 $207,517 - $232,260	660 New	660 $232,000
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $238,038 - $267,792	833 New	833 $240,000
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $508,847 - $600,065	-2,714 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $18,217 - $21,235	-88 Reduced 3.14%	2,714 $583,000
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $164,365 - $219,215	794 Added 39.54%	2,802 $662,000
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $29,911 - $35,462	117 Added 6.19%	2,008 $546,000
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $98,760 - $129,560	-438 Reduced 18.81%	1,891 $549,000
Q1 2020 May 12, 2020	BUY	$199.77 - $247.81 $266,692 - $330,826	1,335 Added 134.31%	2,329 $554,000
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $165,709 - $222,566	994 New	994 $218,000
Q1 2019 May 08, 2019	SELL	$163.73 - $194.7 $36,020 - $42,834	-220 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $33,420 - $42,286	220 New	220 $36,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthspire Advisors, LLC with notifications on news.

Account

Wealthspire Advisors, LLC Vertex Pharmaceuticals Inc Transaction History